Article
Craniosynostosis in molecularly diagnosed Kabuki syndrome: Prevalence and clinical implications.
American journal of medical genetics. Part A - 1 Feb 2024
Nishi Eriko, Miyake Noriko, Kawamura Rie, Hosoki Kana, Hasegawa Yuiko, Matsumoto Naomichi, Okamoto Nobuhiko
Abstract excerpt
Kabuki syndrome (KS) is characterized by growth impairment, psychomotor delay, congenital heart disease, and distinctive facial features. KMT2D and KDM6A have been identified as the causative genes of KS. Craniosynostosis (CS) has been reported in individuals with KS; however, its prevalence and clinical implications remain unclear. In this retrospective study, we investigated the occurrence of CS in individuals...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
